HOUSE 4702118th CongressReferred to the Subcommittee on Health.

Securing Gene Synthesis Act

Last Action: 7/21/2023

Actions

2023-07-21Referred to the Subcommittee on Health.
2023-07-18Referred to the House Committee on Energy and Commerce.
2023-07-18Introduced in House
2023-07-18Introduced in House

CRS Summary

As of 2023-07-18 (00)

Securing Gene Synthesis Act

This bill requires the Department of Health and Human Services to issue regulations to prevent the misuse of de novo gene synthesis products (i.e., manufactured gene products), including screening protocols for providers of these products. Federal agencies and entities that receive federal funds may only purchase such products from providers that comply with the screening protocols.

Cosponsors (2)

Ted Lieu (D-CA)
Julia Brownley (D-CA)

Subjects

Administrative law and regulatory procedures
Congressional oversight
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Genetics
Health technology, devices, supplies
Medical research
Research administration and funding

Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.